Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
PPLT Stock Summary
Top 10 Correlated ETFs
PPLT
In the News

Uranium prices are still ‘nowhere near the peak of the last cycle': Here's why nuclear energy ETFs could power your portfolio
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at ETFs in the nuclear energy sector, which has emerged as one of the best performing ETF themes this year, driven by a notable surge in uranium prices.

PPLT: Dead Money With Lots Of Potential
Platinum prices have declined by 8% in 10 months, making it appear to be a bargain compared to other precious metals. The platinum market is experiencing a deficit in supply, but economic concerns and rising interest rates have prevented a significant rally. The geopolitical landscape, particularly the ongoing war in Ukraine, threatens the supply of platinum from BRICS countries, which dominate worldwide production.

PPLT: Favorable Platinum Outlook But Weak Momentum
PPLT is a convenient tool to match the dynamics of platinum without physically holding the precious metal. The dynamic of platinum prices has reflected China's economic recovery since the beginning of the year. I recommend a Hold action of PPLT's shares, due to mixed expectations of China's recovery and other risk considerations mentioned in the article.

5 Best ETF Areas of April Up At Least 10%
April brings with it seasonal tailwinds for the equity world. Digital Assets, Sugar, Platinum, Biotech and Homebuilding were clear winners in the month.

ALPS' Biotech ETF SBIO Week's Top Performer
In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.

Time for Platinum ETFs as the "Sleeping Beauty" Awakens?
Platinum is rising to new highs. Discover why this under-owned and undervalued metal might be your next investment opportunity.

ETFs to Ride the Platinum Rally
The price of platinum has been on the rise lately on surging demand and tight supply conditions. This has sent a few platinum ETFs to new highs.

Platinum ETF (PPLT) Hits New 52-Week High
For investors seeking momentum, abrdn Physical Platinum Shares ETF PPLT is probably on radar. The fund just hit a 52-week high and is up 32.7% from its 52-week low of $76.09 per share.

CFTC Data Shows The Largest Speculative Palladium Short On Record
Latest CFTC Data shows the largest net speculative short position on record. Current data is a month behind, and we expect it to be even larger.

Palladium: 4 Reasons Why We See A Big Short Squeeze
Palladium positioning is at extreme short levels not seen in the past decade. While Palladium's long-term future has big question marks, we think short term, there are good fundamental reasons for a price rise.
PPLT Financial details
PPLT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 84.65K | 0.09 | |
Book value per share | 0.08 | 0.09 | 0.13 | 84.27K | 0.09 | |
Tangible book value per share | 0.08 | 0.09 | 0.13 | 84.27K | 0.09 | |
Share holders equity per share | 0.08 | 0.09 | 0.13 | 84.27K | 0.09 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 457.7M | 685.16M | 1.04B | 1.21B | 1.21B | |
Enterprise value | 457.7M | 685.16M | 1.04B | 1.21B | 1.21B | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 921.9 | 961.34 | 781.19 | 0 | 1.11K | |
PTB ratio | 921.9 | 961.34 | 781.19 | 0 | 1.11K | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | -696.27K | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 84.27K | 0.09 | |
Working capital | 0 | 0 | 0 | 1138.26B | 1.1M | |
Tangible asset value | 496.72K | 713.08K | 1.33M | 1133.21B | 1.1M | |
Net current asset value | 0 | 0 | 0 | 1133.21B | 1.1M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.08 | 0.08 | 0.09 | 0 | 0 | |
Book value per share | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 | |
Tangible book value per share | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 | |
Share holders equity per share | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 1.06B | 963.74M | 1.21B | 1.02B | 884.16M | |
Enterprise value | 1.06B | 963.74M | 1.21B | 1.02B | 884.16M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 998.03 | 1.05K | 1.11K | 1.06K | 989.78 | |
PTB ratio | 998.03 | 1.05K | 1.11K | 1.06K | 989.78 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -619.04K | -631.96K | 810.14K | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0.08 | 0.08 | 0.09 | 0 | 0 | |
Working capital | 1.06M | 916.8K | 1.1M | 0 | 0 | |
Tangible asset value | 1.06M | 920.33K | 1.1M | 960.79K | 893.73K | |
Net current asset value | 1.06M | 912.33K | 1.1M | 0 | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
PPLT Frequently Asked Questions
What is Aberdeen Standard Physical Platinum Shares ETF stock symbol ?
Aberdeen Standard Physical Platinum Shares ETF is a US stock and trading under the symbol PPLT
What is Aberdeen Standard Physical Platinum Shares ETF stock quote today ?
Aberdeen Standard Physical Platinum Shares ETF stock price is $83.925 today.
Is Aberdeen Standard Physical Platinum Shares ETF stock public?
Yes, Aberdeen Standard Physical Platinum Shares ETF is a publicly traded company.